메뉴 건너뛰기




Volumn 309, Issue 21, 2013, Pages 2223-2231

Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial

(19)  Leuppi, Jörg D a   Schuetz, Philipp c   Bingisser, Roland a   Bodmer, Michael a   Briel, Matthias b   Drescher, Tilman a   Duerring, Ursula a   Henzen, Christoph d   Leibbrandt, Yolanda i   Maier, Sabrina a   Miedinger, David a   Müller, Beat c   Scherr, Andreas a   Schindler, Christian f   Stoeckli, Rolf a   Viatte, Sebastien g,i   Von Garnier, Christophe h   Tamm, Michael a   Rutishauser, Jonas e,i  


Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; MEPREDNISONE; PLACEBO; PREDNISONE; STEROID;

EID: 84878538257     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.5023     Document Type: Article
Times cited : (344)

References (25)
  • 1
    • 69249117423 scopus 로고    scopus 로고
    • New drugs for exacerbations of chronic obstructive pulmonary disease
    • Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):744-755.
    • (2009) Lancet , vol.374 , Issue.9691 , pp. 744-755
    • Hansel, T.T.1    Barnes, P.J.2
  • 2
    • 27744556967 scopus 로고    scopus 로고
    • Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
    • DOI 10.1136/thx.2005.040527
    • Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925-931. (Pubitemid 41598207)
    • (2005) Thorax , vol.60 , Issue.11 , pp. 925-931
    • Soler-Cataluna, J.J.1    Martinez-Garcia, M.A.2    Roman, S.P.3    Salcedo, E.4    Navarro, M.5    Ochando, R.6
  • 3
    • 80955169343 scopus 로고    scopus 로고
    • General practitioner's adherence to the COPD GOLD guidelines: Baseline data of the Swiss COPD Cohort Study
    • Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, Leuppi JD. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly. 2010;140:w13053.
    • (2010) Swiss Med Wkly , vol.140
    • Jochmann, A.1    Neubauer, F.2    Miedinger, D.3    Schafroth, S.4    Tamm, M.5    Leuppi, J.D.6
  • 4
    • 84860767710 scopus 로고    scopus 로고
    • Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort
    • Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly. 2012;142:w13567.
    • (2012) Swiss Med Wkly , vol.142
    • Jochmann, A.1    Scherr, A.2    Jochmann, D.C.3
  • 5
    • 4544382557 scopus 로고    scopus 로고
    • Management of severe COPD
    • Wouters EF. Management of severe COPD. Lancet. 2004;364(9437):883-895.
    • (2004) Lancet , vol.364 , Issue.9437 , pp. 883-895
    • Wouters, E.F.1
  • 6
    • 84925226849 scopus 로고    scopus 로고
    • Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
    • Walters JAE, Wang W, Morley C, Soltani A, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD006897.
    • (2011) Cochrane Database Syst Rev , Issue.10
    • Walters, J.A.E.1    Wang, W.2    Morley, C.3    Soltani, A.4    Wood-Baker, R.5
  • 7
    • 84868337504 scopus 로고    scopus 로고
    • Global strategy for the diagnosis, management and prevention of COPD
    • Accessed April 18, 2013
    • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/ guidelines/guidelines-resources.html. Accessed April 18, 2013.
    • Global Initiative for Chronic Obstructive Lung Disease
  • 9
    • 0033533144 scopus 로고    scopus 로고
    • Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
    • DOI 10.1016/S0140-6736(98)11326-0
    • Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354(9177):456- 460. (Pubitemid 29368923)
    • (1999) Lancet , vol.354 , Issue.9177 , pp. 456-460
    • Davies, L.1    Angus, R.M.2    Calverley, P.M.A.3
  • 12
    • 77953626306 scopus 로고    scopus 로고
    • Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease
    • Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
    • (2010) JAMA , vol.303 , Issue.23 , pp. 2359-2367
    • Lindenauer, P.K.1    Pekow, P.S.2    Lahti, M.C.3    Lee, Y.4    Benjamin, E.M.5    Rothberg, M.B.6
  • 13
    • 0043234165 scopus 로고    scopus 로고
    • Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD
    • DOI 10.1378/chest.124.2.459
    • Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459-467. (Pubitemid 37000120)
    • (2003) Chest , vol.124 , Issue.2 , pp. 459-467
    • Groenewegen, K.H.1    Schols, A.M.W.J.2    Wouters, E.F.M.3
  • 14
    • 79952196700 scopus 로고    scopus 로고
    • Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - The "REDUCE" trial
    • Schuetz P, Leuppi JD, Tamm M, et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - the "REDUCE" trial. Swiss Med Wkly. 2010;140:w13109.
    • (2010) Swiss Med Wkly , vol.140
    • Schuetz, P.1    Leuppi, J.D.2    Tamm, M.3
  • 15
    • 0023164742 scopus 로고
    • Antiobiotic therapy in exacerbations of chronic obstructive pulmonary disease
    • Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204. (Pubitemid 17009877)
    • (1987) Annals of Internal Medicine , vol.106 , Issue.2 , pp. 196-204
    • Anthonisen, N.R.1    Manfreda, J.2    Warren, C.P.W.3
  • 17
    • 84871484789 scopus 로고    scopus 로고
    • Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement
    • CONSORT Group
    • Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604.
    • (2012) JAMA , vol.308 , Issue.24 , pp. 2594-2604
    • Piaggio, G.1    Elbourne, D.R.2    Pocock, S.J.3    Evans, S.J.W.4    Altman, D.G.5
  • 18
    • 0035035768 scopus 로고    scopus 로고
    • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary
    • Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276. (Pubitemid 32378468)
    • (2001) American Journal of Respiratory and Critical Care Medicine , vol.163 , Issue.5 , pp. 1256-1276
    • Pauwels, R.A.1    Buist, A.S.2    Calverley, P.M.A.3    Jenkins, C.R.4    Hurd, S.S.5
  • 19
    • 0034064973 scopus 로고    scopus 로고
    • Toward a consensus definition for COPD exacerbations
    • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5)(suppl 2):398S-401S. (Pubitemid 30314474)
    • (2000) Chest , vol.117 , Issue.5 SUPPL. 2
    • Rodriguez-Roisin, R.1
  • 20
    • 0008485492 scopus 로고    scopus 로고
    • Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
    • Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. (Pubitemid 29296676)
    • (1999) Thorax , vol.54 , Issue.7 , pp. 581-586
    • Bestall, J.C.1    Paul, E.A.2    Garrod, R.3    Garnham, R.4    Jones, P.W.5    Wedzicha, J.A.6
  • 21
    • 0037062141 scopus 로고    scopus 로고
    • Azithromycin for acute bronchitis: A randomised, double-blind, controlled trial
    • DOI 10.1016/S0140-6736(02)08597-5
    • Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet. 2002;359(9318):1648-1654. (Pubitemid 34518524)
    • (2002) Lancet , vol.359 , Issue.9318 , pp. 1648-1654
    • Evans, A.T.1    Husain, S.2    Durairaj, L.3    Sadowski, L.S.4    Charles-Damte, M.5    Wang, Y.6
  • 22
    • 1342265610 scopus 로고    scopus 로고
    • Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial
    • DOI 10.1016/S0140-6736(04)15591-8
    • Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600-607. (Pubitemid 38264177)
    • (2004) Lancet , vol.363 , Issue.9409 , pp. 600-607
    • Christ-Crain, M.1    Jaccard-Stolz, D.2    Bingisser, R.3    Gencay, M.M.4    Huber, P.R.5    Tamm, M.6    Muller, B.7
  • 23
    • 0035089716 scopus 로고    scopus 로고
    • Systemic glucocorticoids in severe exacerbations of COPD
    • DOI 10.1378/chest.119.3.726
    • Sayiner A, Aytemur ZA, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 2001;119(3):726-730. (Pubitemid 32197640)
    • (2001) Chest , vol.119 , Issue.3 , pp. 726-730
    • Sayiner, A.1    Aytemur, Z.A.2    Cirit, M.3    Unsal, I.4
  • 24
    • 33846311358 scopus 로고    scopus 로고
    • Antibiotic treatment of exacerbations of COPD: A randomized, controlled trial comparing procalcitonin-guidance with standard therapy
    • DOI 10.1378/chest.06-1500
    • Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9-19. (Pubitemid 46122969)
    • (2007) Chest , vol.131 , Issue.1 , pp. 9-19
    • Stolz, D.1    Christ-Grain, M.2    Bingisser, R.3    Leuppi, J.4    Miedinger, D.5    Muller, C.6    Huber, P.7    Muller, B.8    Tamm, M.9
  • 25
    • 78649745984 scopus 로고    scopus 로고
    • Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
    • Bridevaux PO, Probst-Hensch NM, Schindler C, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J. 2010;36(6):1259-1269.
    • (2010) Eur Respir J , vol.36 , Issue.6 , pp. 1259-1269
    • Bridevaux, P.O.1    Probst-Hensch, N.M.2    Schindler, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.